Quanyi Lu

Summary

Country: China

Publications

  1. ncbi [Clinical study on transplantation of G-CSF-mobilized allo-PBSC and allo-bone marrow for leukemia patients]
    Quan Yi Lu
    Department of Hematology, Teaching Hospital, Zhongshan Hospital of Xiamen, Fujian Medical University, Xiamen 361004, China
    Zhongguo Shi Yan Xue Ye Xue Za Zhi 13:326-8. 2005
  2. ncbi Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways
    Quanyi Lu
    Division of Hematology Oncology, New York Medical College, Valhalla, NY 10595, USA
    J Hematol Oncol 1:6. 2008
  3. ncbi [Treatment of stage IV neuroblastoma with allogeneic hematopoietic stem cell transplantation in children]
    Quan Yi Lu
    Department of Hematology, Zhongshan Hospital of Xiamen University, Xiamen, Fujian 361004, China
    Zhongguo Dang Dai Er Ke Za Zhi 10:464-6. 2008

Collaborators

Detail Information

Publications3

  1. ncbi [Clinical study on transplantation of G-CSF-mobilized allo-PBSC and allo-bone marrow for leukemia patients]
    Quan Yi Lu
    Department of Hematology, Teaching Hospital, Zhongshan Hospital of Xiamen, Fujian Medical University, Xiamen 361004, China
    Zhongguo Shi Yan Xue Ye Xue Za Zhi 13:326-8. 2005
    ..In conclusion, allogeneic transplantation of G-CSF mobilized PBSC plus BM was safe and effective treatment for patients with leukemia, the therapy provides rapid and sustained engraftment without increase in incidence of aGVHt and cGVHD...
  2. ncbi Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways
    Quanyi Lu
    Division of Hematology Oncology, New York Medical College, Valhalla, NY 10595, USA
    J Hematol Oncol 1:6. 2008
    ..We conclude that PHI has dual epigenetic effects on p16 hypomethylation and histone hyperacetylation in myeloma cells and targets several critical processes of myeloma proliferation...
  3. ncbi [Treatment of stage IV neuroblastoma with allogeneic hematopoietic stem cell transplantation in children]
    Quan Yi Lu
    Department of Hematology, Zhongshan Hospital of Xiamen University, Xiamen, Fujian 361004, China
    Zhongguo Dang Dai Er Ke Za Zhi 10:464-6. 2008
    ..At present there is no effective therapeutic approach for stage IV neuroblastoma. We report our experience with allogenic hematopoietic stem cell transplantation as a means of treating this disorder in one child...